Avoiding Antitrust Issues - - BioPharm International

ADVERTISEMENT

Avoiding Antitrust Issues


BioPharm International
Volume 1, Issue 8

46. Federal Trade Commission v Mylan Laboratories, 62 FSupp 2d 25 (DDC 1999).

47. US Department of Justice and Federal Trade Commission. Antitrust Guidelines for the Licensing of Intellectual Property (IP Antitrust Guidelines). Washington, D.C. 1995, April 6. Available at: http:// http://www.usdoj.gov/atr/public/guidelines/ipguide.htm.

Thomas J. Horton, J.D., is an antitrust and litigation partner at Thelen Reid & Priest LLP, 701 Eighth Street, NW, Washington, DC 20001, 202.508-4025, fax 202.508.4321,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
FDA Develops Alternative Assay to Increase Availability of Influenza Vaccines
April 10, 2014
Merck Announes Management Changes
April 7, 2014
Author Guidelines
Source: BioPharm International,
Click here